242 related articles for article (PubMed ID: 35383859)
21. A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast.
Reed AD; Pensa S; Steif A; Stenning J; Kunz DJ; Porter LJ; Hua K; He P; Twigger AJ; Siu AJQ; Kania K; Barrow-McGee R; Goulding I; Gomm JJ; Speirs V; Jones JL; Marioni JC; Khaled WT
Nat Genet; 2024 Apr; 56(4):652-662. PubMed ID: 38548988
[TBL] [Abstract][Full Text] [Related]
22. Germline large genomic alterations on 7q in patients with multiple primary cancers.
Villacis RA; Basso TR; Canto LM; Nóbrega AF; Achatz MI; Rogatto SR
Sci Rep; 2017 Jan; 7():41677. PubMed ID: 28139749
[TBL] [Abstract][Full Text] [Related]
23.
Gorodetska I; Kozeretska I; Dubrovska A
J Cancer; 2019; 10(9):2109-2127. PubMed ID: 31205572
[TBL] [Abstract][Full Text] [Related]
24. Review on the Role of BRCA Mutations in Genomic Screening and Risk Stratification of Prostate Cancer.
Kalampokis N; Zabaftis C; Spinos T; Karavitakis M; Leotsakos I; Katafigiotis I; van der Poel H; Grivas N; Mitropoulos D
Curr Oncol; 2024 Feb; 31(3):1162-1169. PubMed ID: 38534919
[TBL] [Abstract][Full Text] [Related]
25. Characterization of immortalized ovarian epithelial cells with BRCA1/2 mutation.
Komatsu H; Okawa M; Kazuki Y; Kazuki K; Hichiwa G; Shimoya K; Sato S; Taniguchi F; Oshimura M; Harada T
Hum Cell; 2024 Apr; ():. PubMed ID: 38615309
[TBL] [Abstract][Full Text] [Related]
26. Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinoma.
Scimeca M; Rovella V; Caporali S; Shi Y; Bischof J; Woodsmith J; Tisone G; Sica G; Amelio I; Melino G; Mauriello A; Bove P
Discov Oncol; 2024 Mar; 15(1):80. PubMed ID: 38512353
[TBL] [Abstract][Full Text] [Related]
27. BRCA Mutations and Fertility Preservation.
Dias Nunes J; Demeestere I; Devos M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203374
[TBL] [Abstract][Full Text] [Related]
28. Ketogenic Diet and Breast Cancer: Recent Findings and Therapeutic Approaches.
Urzì AG; Tropea E; Gattuso G; Spoto G; Marsala G; Calina D; Libra M; Falzone L
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892432
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs as Potential Biomarkers in Gynecological Cancers.
Miśkiewicz J; Mielczarek-Palacz A; Gola JM
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371799
[TBL] [Abstract][Full Text] [Related]
30. Polygenic Risk Score Predicts Modified Risk in
Berga-Švītiņa E; Maksimenko J; Miklaševičs E; Fischer K; Vilne B; Mägi R
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296919
[TBL] [Abstract][Full Text] [Related]
31. HIPEC for gynaecological malignancies: A last update (Review).
Margioula-Siarkou C; Almperis A; Papanikolaou A; Laganà AS; Mavromatidis G; Guyon F; Dinas K; Petousis S
Med Int (Lond); 2023; 3(3):25. PubMed ID: 37205988
[TBL] [Abstract][Full Text] [Related]
32. NUF2 overexpression contributes to epithelial ovarian cancer progression
Leng R; Meng Y; Sun X; Zhao Y
Front Oncol; 2022; 12():1057198. PubMed ID: 36620547
[TBL] [Abstract][Full Text] [Related]
33. Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes.
Marrelli D; Ansaloni L; Federici O; Asero S; Carbone L; Marano L; Baiocchi G; Vaira M; Coccolini F; Di Giorgio A; Framarini M; Gelmini R; Palopoli C; Accarpio F; Fagotti A
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497490
[TBL] [Abstract][Full Text] [Related]
34.
Wang C; Yin Y; Sun Z; Wang Y; Li F; Wang Y; Zhang Z; Chen X
Dis Markers; 2022; 2022():2334338. PubMed ID: 36479043
[TBL] [Abstract][Full Text] [Related]
35. Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer.
Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
[TBL] [Abstract][Full Text] [Related]
36. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
[TBL] [Abstract][Full Text] [Related]
37. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC.
Guo Q; Qiu P; Yao Q; Chen J; Lin J
Dis Markers; 2022; 2022():4964793. PubMed ID: 36157217
[TBL] [Abstract][Full Text] [Related]
38. BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation.
Chen S; Li Z; Wang Y; Fan S
Front Oncol; 2022; 12():952425. PubMed ID: 36059652
[TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis.
Lv S; Sun J; Sun J
Anal Cell Pathol (Amst); 2022; 2022():9042380. PubMed ID: 35837294
[TBL] [Abstract][Full Text] [Related]
40. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer.
Hu X; Li D; Fu Y; Zheng J; Feng Z; Cai J; Wang P
Front Oncol; 2022; 12():917439. PubMed ID: 35785201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
